tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avalo Therapeutics appoints Kevin Lind to board of directors
PremiumThe FlyAvalo Therapeutics appoints Kevin Lind to board of directors
26d ago
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
Premium
The Fly
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
1M ago
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
Premium
The Fly
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
1M ago
Target downgraded, Salesforce upgraded: Wall Street’s top analyst calls
PremiumThe FlyTarget downgraded, Salesforce upgraded: Wall Street’s top analyst calls
2M ago
Avalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Avalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
Avalo Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Avalo Therapeutics Reports Q2 2025 Financial Results
2M ago
Avalo Therapeutics Appoints Dr. Rita Jain to Board
PremiumCompany AnnouncementsAvalo Therapeutics Appoints Dr. Rita Jain to Board
4M ago
Avalo Therapeutics appoints Jain to its board of directors
Premium
The Fly
Avalo Therapeutics appoints Jain to its board of directors
4M ago
Avalo Therapeutics Holds 2025 Annual Meeting
Premium
Company Announcements
Avalo Therapeutics Holds 2025 Annual Meeting
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100